Finally, abnormal expression of NEK2 has been observed in various cancers, including lung, pancreatic, prostate, and breast, as well as hepatocellular carcinoma and multiple myeloma [86,87,88]. The gene discussed is NEK2; the disease is plasma cell myeloma.